Overview
- Provides an overview of nanotechnology in drug delivery
- The only book to focus on the design, development, and delivery of nanoparticles by the mucosal routes of administration
- Discusses the interaction of the host's immune system with nanoparticles
- Reviews regulatory aspects of nanotechnology in product development
Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series (AAPS, volume 41)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (11 chapters)
-
Background
-
Nanoparticle-Based Mucosal Delivery of Drugs and Biologics
-
Host Interactions with Nanoparticles
Keywords
About this book
Editors and Affiliations
About the editors
Dr. Kunda is an Assistant Professor in the Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences at the St. John’s University, New York, USA. Prior to joining St. John’s, Dr. Kunda was a post-doctoral fellow at the College of Pharmacy, University of New Mexico, Albuquerque, NM, with a research focus in aerosol drug and vaccine delivery. Dr. Kunda received his Bachelor’s in Pharmacy (Honors) from Birla Institute of Technology & Science-Pilani(BITS-Pilani), India, Master’s in Drug Delivery from the London School of Pharmacy, London, UK and a Ph.D. in Formulation and Drug Delivery from Liverpool John Moores University in Liverpool, UK. Dr. Kunda’s dissertation focused on developing a novel pneumococcal vaccine that can be inhaled as a dry powder.
Dr. Kunda’s research is multi-disciplinary and his current research interests include the use of nanotechnology in developing therapeutics against infectious disease and cancer, synthesizing polymeric nanoparticles and attaching targeting moieties for site-specific delivery, formulation of amorphous solid dispersions, immunotherapy, and drug and vaccine formulation for pulmonary delivery. Dr. Kunda’s laboratory specializes in developing dry powder biologics that do not require cold-chain for storage and transport thereby decreasing the cost of biologics-based products significantly. Dr. Kunda serves as an editorial board member of PLoS One and as a Review Editor for the Vaccines and Molecular Therapeutics section of the Frontiers in Immunology and Frontiers in Public Health journals. In addition, Dr. Kunda acts a reviewer for many high-impact journals such as International Journal of Pharmaceutics, ACS Applied Materials & Interfaces, Toxicology in vitro, Pharmaceutics, Microorganisms, Pharmaceuticals, Human Vaccines & Immunotherapeutics, and PLoS One.
Bibliographic Information
Book Title: Mucosal Delivery of Drugs and Biologics in Nanoparticles
Editors: Pavan Muttil, Nitesh K. Kunda
Series Title: AAPS Advances in the Pharmaceutical Sciences Series
DOI: https://doi.org/10.1007/978-3-030-35910-2
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: American Association of Pharmaceutical Scientists 2020
Hardcover ISBN: 978-3-030-35909-6Published: 19 March 2020
Softcover ISBN: 978-3-030-35912-6Published: 19 March 2021
eBook ISBN: 978-3-030-35910-2Published: 18 March 2020
Series ISSN: 2210-7371
Series E-ISSN: 2210-738X
Edition Number: 1
Number of Pages: VIII, 277
Number of Illustrations: 10 b/w illustrations, 42 illustrations in colour